MIRN519A1: A Potential Drug Target and Biomarker (G574496)

Target Name: MIR519A1

NCBI ID: G574496

MIR519A1

MIRN519A1: A Potential Drug Target and Biomarker

MIR519A1, also known as MIRN519A1, is a protein that is expressed in various tissues throughout the body, including the brain, lungs, heart, and gastrointestinal tract. It is a member of the MIRNA (microRNA) family, which are a group of non-coding RNAs that play a critical role in post-transcriptional gene regulation.

MIRN519A1 is unique due to its highly specificity in its target audience. It is specifically expressed in the brain, where it is known to interact with a protein called TrkB, which is a key regulator of the brain-gut axis. MIRN519A1 has been shown to play a role in the regulation of various cellular processes in the brain, including cell survival, proliferation, and differentiation.

In addition to its role in the brain, MIRN519A1 has also been shown to be involved in several other biological processes in the body. For example, it has been shown to be involved in the regulation of inflammation and immune response, as well as in the regulation of cell signaling pathways that are involved in various diseases, such as cancer, neurodegenerative diseases, and autoimmune diseases.

Due to its unique role in various biological processes, MIRN519A1 has been identified as a potential drug target. Researchers have been studying the potential mechanisms of MIRN519A1 and its potential therapeutic applications in these areas.

One of the main advantages of MIRN519A1 as a drug target is its small size and the ease with which it can be modified. MIRN519A1 consists of only 24 amino acid residues and has a low molecular weight, which makes it relatively easy to synthesize and purify. Additionally, its small size allows for the use of various techniques for its manipulation, such as genetic modification, expression, and purification.

Another advantage of MIRN519A1 is its expression pattern in various tissues. As mentioned earlier, MIRN519A1 is expressed in the brain, where it is involved in the regulation of various cellular processes. This makes it a potential target for drugs that are designed to modulate brain function, such as those that are used to treat neurological and psychiatric disorders.

In addition to its potential therapeutic applications, MIRN519A1 also has the potential to serve as a biomarker for various diseases. Its expression pattern in various tissues makes it a potential indicator of disease status, and its potential therapeutic applications make it a valuable tool for the diagnosis and treatment of disease.

Overall, MIRN519A1 is a protein that has the potential to serve as a drug target and biomarker for a variety of diseases. Further research is needed to fully understand its mechanisms of action and its potential therapeutic applications.

Protein Name: MicroRNA 519a-1

The "MIR519A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR519A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets